Published in World J Surg on October 01, 2009
Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology (2012) 1.33
Imbalance of angiogenesis in diabetic complications: the mechanisms. Int J Prev Med (2012) 1.07
Effect of dental status on changes in mastication in patients with obesity following bariatric surgery. PLoS One (2011) 0.84
Intentional weight loss and dose reductions of anti-diabetic medications--a retrospective cohort study. PLoS One (2012) 0.83
Overview of emerging concepts in metabolic surgery. Perm J (2010) 0.83
Thyroidectomy as primary treatment optimizes body mass index in patients with hyperthyroidism. Ann Surg Oncol (2014) 0.80
Botulinum toxin for chronic anal fissure after biliopancreatic diversion for morbid obesity. World J Gastroenterol (2012) 0.76
Evaluation of the Swedish adjustable gastric band VC (SAGB-VC) in an Australian population: early results. Can J Surg (2013) 0.75
Outcomes of One Anastomosis Gastric Bypass in 472 Diabetic Patients. Obes Surg (2017) 0.75
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73
Global and societal implications of the diabetes epidemic. Nature (2001) 25.18
Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34
Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med (2007) 18.45
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med (2004) 17.91
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
Economic costs of diabetes in the U.S. In 2007. Diabetes Care (2008) 15.73
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA (2008) 13.69
Adipose tissue as an endocrine organ. J Clin Endocrinol Metab (2004) 11.94
Long-term mortality after gastric bypass surgery. N Engl J Med (2007) 10.75
Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg (1995) 9.02
U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes (1995) 8.95
Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med (1995) 7.62
Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care (1994) 7.11
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med (2005) 6.88
Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg (2003) 6.50
Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia (1991) 5.32
Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest (2002) 5.31
Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes (2004) 4.73
Type 2 diabetes-a matter of beta-cell life and death? Science (2005) 4.46
Increases in morbid obesity in the USA: 2000-2005. Public Health (2007) 4.33
Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg (2006) 4.30
Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab (2008) 4.19
The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg (2006) 3.97
How obesity causes diabetes: not a tall tale. Science (2005) 3.89
beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev (2007) 3.85
Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care (2000) 3.37
Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group. Diabetes Care (1999) 3.36
The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg (2006) 2.93
Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr (1992) 2.62
Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg (2005) 2.59
Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care (2002) 2.51
Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med (2003) 2.41
Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab (2004) 2.21
Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res (1999) 2.11
Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation. Am J Clin Nutr (2008) 2.11
Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care (2008) 2.10
Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis. Am J Med (2004) 2.07
Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diabetes Care (2009) 2.04
Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med (2009) 2.02
Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care (2009) 2.00
Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery (2004) 1.94
Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg (2003) 1.83
Redefining type 2 diabetes: 'diabesity' or 'obesity dependent diabetes mellitus'? Obes Rev (2000) 1.76
Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases. Surg Obes Relat Dis (2007) 1.68
The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976-2004. Prev Med (2007) 1.67
Temporal trends in BMI among adults with diabetes. Diabetes Care (2001) 1.64
Gastric bypass and nesidioblastosis--too much of a good thing for islets? N Engl J Med (2005) 1.54
Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia (2008) 1.50
Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab (2002) 1.41
Post-gastric bypass hyperinsulinism with nesidioblastosis: subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia. J Gastrointest Surg (2006) 1.39
First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis (2008) 1.30
Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg (2008) 1.25
Etiology of type II diabetes mellitus: role of the foregut. World J Surg (2001) 1.25
Type II diabetic subjects lose less weight than their overweight nondiabetic spouses. Diabetes Care (1988) 1.25
Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Ann Surg (2009) 1.20
Severe recurrent hypoglycemia after gastric bypass surgery. Obes Surg (2008) 1.15
Diabetes disease stage predicts weight loss outcomes with long-term appetite suppressants. Obes Res (2000) 1.13
Abnormalities in insulin secretion in type 2 diabetes mellitus. Diabetes Metab (2008) 1.12
Free fatty acids-the link between obesity and insulin resistance. Endocr Pract (2001) 1.07
Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabet Med (2003) 1.05
Hyperinsulinemic hypoglycemia developing late after gastric bypass. Obes Surg (2007) 1.03
Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond. J Biomed Sci (2008) 1.02
Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes (Lond) (2008) 1.02
Regulation of insulin sensitivity by adipose tissue-derived hormones and inflammatory cytokines. Curr Opin Lipidol (2004) 0.99
Surgery as an effective early intervention for diabesity: why the reluctance? Diabetes Care (2005) 0.97
Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM. Diabetes (1994) 0.94
Relationships between diabetes duration, metabolic control and beta-cell function in a representative population of type 2 diabetic patients in Sweden. Diabet Med (1994) 0.93
Duodenal- jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov (2007) 0.87
Referral for a bariatric surgical consultation: it is time to set a standard of care. Obes Surg (2008) 0.82
Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction. J Clin Endocrinol Metab (1996) 0.82
From the NIH: Successful diet and exercise therapy is conducted in Vermont for "diabesity". JAMA (1980) 0.79